Growth/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration

被引:7
作者
Dogon, Geoffrey [1 ]
Rigal, Eve [1 ]
Potel, Eliot [1 ]
Josse, Marie [1 ]
Rochette, Luc [1 ]
Bejot, Yannick [1 ,2 ]
Vergely, Catherine [1 ]
机构
[1] Univ Burgundy, Fac Hlth Sci, Res Team Physiopathol & Epidemiol Cerebro Cardiova, 7 Bd Jeanne Arc, F-21000 Dijon, France
[2] Dijon Univ Hosp, Dept Neurol, Dijon, France
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
GDF-15; Ischemia-reperfusion injury; Heart; Preconditioning; Cardioprotection; GROWTH-DIFFERENTIATION FACTOR-15; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; RECEPTOR; PATHWAY; BETA; MORTALITY; INSIGHTS; EVENTS; STRESS;
D O I
10.1038/s41598-024-63880-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Growth/differentiation factor-15 (GDF15) is considered an unfavourable prognostic biomarker for cardiovascular disease in clinical data, while experimental studies suggest it has cardioprotective potential. This study focuses on the direct cardiac effects of GDF15 during ischemia-reperfusion injury in Wistar male rats, employing concentrations relevant to patients at high cardiovascular risk. Initially, we examined circulating levels and heart tissue expression of GDF15 in rats subjected to ischemia-reperfusion and sham operations in vivo. We then evaluated the cardiac effects of GDF15 both in vivo and ex vivo, administering recombinant GDF15 either before 30 min of ischemia (preconditioning) or at the onset of reperfusion (postconditioning). We compared infarct size and cardiac contractile recovery between control and rGDF15-treated rats. Contrary to our expectations, ischemia-reperfusion did not increase GDF15 plasma levels compared to sham-operated rats. However, cardiac protein and mRNA expression increased in the infarcted zone of the ischemic heart after 24 h of reperfusion. Notably, preconditioning with rGDF15 had a cardioprotective effect, reducing infarct size both in vivo (65 +/- 5% in control vs. 42 +/- 6% in rGDF15 groups) and ex vivo (60 +/- 4% in control vs. 45 +/- 4% in rGDF15 groups), while enhancing cardiac contractile recovery ex vivo. However, postconditioning with rGDF15 did not alter infarct size or the recovery of contractile parameters in vivo or ex vivo. These novel findings reveal that the short-term exogenous administration of rGDF15 before ischemia, at physiologically relevant levels, protects the heart against ischemia-reperfusion injury in both in vivo and ex vivo settings. The ex vivo results indicate that rGDF15 operates independently of the inflammatory, endocrine and nervous systems, suggesting direct and potent cardioprotective properties against ischemia-reperfusion injury.
引用
收藏
页数:14
相关论文
共 42 条
[31]   Therapeutic and Diagnostic Value of Caspase-12 and Study of Growth Differentiation Factor-15 in Patients with Acute Myocardial Infarction [J].
Sun, Changqing ;
Li, Xiulin ;
Wang, Daoqing ;
Wang, Liming .
IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (12) :2339-2347
[32]   Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction [J].
Rueda, Ferran ;
Lupon, Josep ;
Garcia-Garcia, Cosme ;
Cediel, German ;
Aranda Nevado, M. Cruz ;
Serra Gregori, Judith ;
Labata, Carlos ;
Oliveras, Teresa ;
Ferrer, Marc ;
de Diego, Oriol ;
Serra, Jordi ;
Revuelta Lopez, Elena ;
Bayes-Genis, Antoni .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (07) :1093-1101
[33]   Growth Differentiation Factor 15 is Related with Left Ventricular Recovery in Patients with ST-Elevation Myocardial Infarction after Successful Reperfusion by Primary Percutaneous Intervention [J].
Somuncu, Mustafa Umut ;
Tatar, Fatih Pasa ;
Kalayci, Belma ;
Avci, Ahmet ;
Gudul, Naile Eris ;
Uygur, Begum ;
Demir, Ali Riza ;
Can, Murat .
ACTA CARDIOLOGICA SINICA, 2021, 37 (05) :473-483
[34]   Growth differentiation factor-15 as a negative predictor for microvascular obstruction in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention [J].
Wu, Xiang ;
Bai, Jian ;
Tan, Ying ;
Wei, Zhonghai ;
Dai, Qing ;
Kang, Lina ;
Wang, Lian ;
Chen, Jianzhou ;
Yang, Yining ;
Wang, Kun ;
Wu, Han .
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2024, 40 (04) :863-871
[35]   The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker) [J].
Omar, Massar ;
Jensen, Jesper ;
Kistorp, Caroline ;
Hojlund, Kurt ;
Videbaek, Lars ;
Tuxen, Christian ;
Larsen, Julie H. ;
Andersen, Camilla F. ;
Gustafsson, Finn ;
Kober, Lars ;
Schou, Morten ;
Moller, Jacob Eifer .
CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
[36]   Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery [J].
Guenancia, Charles ;
Kahli, Abdelkader ;
Laurent, Gabriel ;
Hachet, Olivier ;
Malapert, Ghislain ;
Grosjean, Sandrine ;
Girard, Claude ;
Vergely, Catherine ;
Bouchot, Olivier .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 :66-71
[37]   Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study [J].
Sun, Ling ;
Zhou, Xuejun ;
Jiang, Jianguang ;
Zang, Xuan ;
Chen, Xin ;
Li, Haiyan ;
Cao, Haitao ;
Wang, Qingjie .
PLOS ONE, 2018, 13 (05)
[38]   Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support [J].
Lok, Sjoukje I. ;
Winkens, Bjorn ;
Goldschmeding, Roel ;
van Geffen, Ankie J. P. ;
Nous, Fay M. A. ;
van Kuik, Joyce ;
van der Weide, Petra ;
Klopping, Corinne ;
Kirkels, J. Hans ;
Lahpor, Jaap R. ;
Doevendans, Pieter A. ;
de Jonge, Nicolaas ;
de Weger, Roel A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (11) :1249-1256
[39]   The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients [J].
Mayer, Otto, Jr. ;
Bruthans, Jan ;
Seidlerova, Jitka ;
Karnosova, Petra ;
Materankova, Marketa ;
Gelzinsky, Julius ;
Rychecka, Martina ;
Opatrny, Jan ;
Wohlfahrt, Peter ;
Kucera, Radek ;
Trefil, Ladislav ;
Cifkova, Renata ;
FilipovskY, Jan ;
Vermeer, Cees .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (02) :540-551
[40]   Differential Expression of Caveolin-3, Suppression of Tumorigenicity 2, and Growth Differentiation Factor-15 Genes and Their Association with Acute Myocardial Infarction: A Cross-Sectional Study in a Multi-Specialty Hospital in Tamil Nadu [J].
Venugopal, Priyanka ;
Logu, Kannika ;
Balakrishnan, Karthikeyan ;
Subbaih, Usha ;
Kandadai, Sriram Damal ;
George, Melvin .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2023, 27 (03) :109-119